Cargando…
High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels.
High-dose etoposide (2.0-2.4 g m(-2)) with granulocyte colony-stimulating factor (G-CSF) is an effective strategy to mobilize peripheral blood progenitor cells (PBPCs), although in some patients this is associated with significant toxicity. Sixty-three patients with malignancy were enrolled into thi...
Autores principales: | Kanfer, E. J., McGuigan, D., Samson, D., Abboudi, Z., Abrahamson, G., Apperley, J. F., Chilcott, S., Craddock, C., Davis, J., MacDonald, C., Macdonald, D., Olavarria, E., Philpott, N., Rustin, G. J., Seckl, M. J., Sekhar, M., Stern, S., Newlands, E. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063139/ https://www.ncbi.nlm.nih.gov/pubmed/9764585 |
Ejemplares similares
-
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004) -
High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.
por: Lyttelton, M. P., et al.
Publicado: (1998) -
High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
por: El-Helw, L M, et al.
Publicado: (2005) -
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
por: Gaffan, J, et al.
Publicado: (2003) -
A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.
por: Lowis, S. P., et al.
Publicado: (1998)